Debt-to-equity in % of OCULAR THERAPEUTIX, INC from Q1 2015 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
OCULAR THERAPEUTIX, INC quarterly Debt-to-equity history and change rate from Q1 2015 to Q3 2025.
  • OCULAR THERAPEUTIX, INC Debt-to-equity for the quarter ending 30 Sep 2025 was 50.7 %, a 9.36% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

OCULAR THERAPEUTIX, INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 50.7 +4.34 +9.36% 30 Sep 2025
Q2 2025 45.7 -20.5 -31% 30 Jun 2025
Q1 2025 42.7 -68.2 -61.5% 31 Mar 2025
Q4 2024 37.9 -457 -92.3% 31 Dec 2024
Q3 2024 46.4 -858 -94.9% 30 Sep 2024
Q2 2024 66.2 -426 -86.5% 30 Jun 2024
Q1 2024 111 -177 -61.5% 31 Mar 2024
Q4 2023 495 +301 +155% 31 Dec 2023
Q3 2023 904 +746 +470% 30 Sep 2023
Q2 2023 492 +348 +242% 30 Jun 2023
Q1 2023 288 +137 +91% 31 Mar 2023
Q4 2022 194 +29.8 +18.1% 31 Dec 2022
Q3 2022 159 -32.7 -17.1% 30 Sep 2022
Q2 2022 144 -110 -43.3% 30 Jun 2022
Q1 2022 151 -191 -55.9% 31 Mar 2022
Q4 2021 164 -546 -76.9% 31 Dec 2021
Q3 2021 191 +3.02K 30 Sep 2021
Q2 2021 254 -14.4K -98.3% 30 Jun 2021
Q1 2021 342 -5.82K -94.5% 31 Mar 2021
Q4 2020 710 -52.2 -6.85% 31 Dec 2020
Q3 2020 -2.83K -3.17K -944% 30 Sep 2020
Q2 2020 14.7K +14.5K +7605% 30 Jun 2020
Q1 2020 6.16K +6.06K +5694% 31 Mar 2020
Q4 2019 763 +698 +1078% 31 Dec 2019
Q3 2019 335 +272 +426% 30 Sep 2019
Q2 2019 190 +120 +171% 30 Jun 2019
Q1 2019 106 +33 +44.9% 31 Mar 2019
Q4 2018 64.8 -2.04 -3.06% 31 Dec 2018
Q3 2018 63.8 +8.83 +16.1% 30 Sep 2018
Q2 2018 70.1 +25.2 +56.3% 30 Jun 2018
Q1 2018 73.4 +37.5 +105% 31 Mar 2018
Q4 2017 66.8 +35.6 +114% 31 Dec 2017
Q3 2017 55 +28.4 +107% 30 Sep 2017
Q2 2017 44.8 +21 +87.8% 30 Jun 2017
Q1 2017 35.9 +14.2 +65.6% 31 Mar 2017
Q4 2016 31.2 +8.04 +34.7% 31 Dec 2016
Q3 2016 26.6 +1.57 +6.27% 30 Sep 2016
Q2 2016 23.9 -3.29 -12.1% 30 Jun 2016
Q1 2016 21.7 -49.6 -69.6% 31 Mar 2016
Q4 2015 23.2 31 Dec 2015
Q3 2015 25 30 Sep 2015
Q2 2015 27.2 30 Jun 2015
Q1 2015 71.3 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.